UOC of Internal Medicine-Center of Hypertension and Nephrology Unit, Department of Systems Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.
School of Applied Medical, Surgical Sciences, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.
Cardiovasc Ther. 2020 Jun 13;2020:1807941. doi: 10.1155/2020/1807941. eCollection 2020.
Nephropathic patients show elevated cardiovascular morbidity and mortality compared to the general population. In order to delve deeper into the understanding of this phenomenon, it is necessary to recognize risk factors that are distinctive to the uremic state, such as oxidative stress and chronic low-grade inflammation. Moreover, gender differences have been reported in nephrology, as it has been observed that chronic kidney disease has higher prevalence in males than in females. The use of an oral food supplement (OFS) containing natural active compounds from L., Garcinia cambogia, L., artichoke, and L. which are virtually devoid from side effects, but rich in antioxidant and antiradical properties, could represent a valid therapeutic adjunct in the clinical management of nephropathic patients. Moreover, quantitative analysis performed on such compounds showed that they expressed good total antioxidant (7.28 gallic acid equivalents) and antiradical activity (above 80%). In this study, 23 male nephropathic patients and 10 age and body composition parameter matched healthy males (control group) were enrolled and took 3 cps/day of OFS for 5 weeks. At the end of the study, the nephropathic patient group showed a statistically significant reduction in the following laboratory parameters: total cholesterol (TC) ( = 0.044), atherogenic index TC/high-density lipoprotein cholesterol ( = 0.010), inflammatory parameters (C-reactive protein, = 0.048, and erythrocyte sedimentation rate, = 0.019), systolic ( = 0.044), and diastolic arterial blood pressure ( = 0.003). Regarding body composition, there was an increase in total body water % ( = 0.035) with redistribution of extracellular water % ( = 0.030) and intracellular water % ( = 0.049). In the control group, there was a reduction in fat mass % ( = 0.017) and extracellular water % ( = 0.047). Therefore, this OFS may represent a valid adjunct therapy to counteract comorbidities related to uremia.
肾病患者的心血管发病率和死亡率高于普通人群。为了更深入地了解这一现象,有必要认识到尿毒症特有的风险因素,如氧化应激和慢性低度炎症。此外,肾病学中也报道了性别差异,因为观察到慢性肾脏病在男性中的患病率高于女性。使用一种含有天然活性化合物的口服食品补充剂(OFS),这些化合物来自 L.、藤黄果、L.、朝鲜蓟和 L.,几乎没有副作用,但富含抗氧化和抗自由基特性,可能是肾病患者临床治疗的有效辅助手段。此外,对这些化合物进行的定量分析表明,它们具有良好的总抗氧化(7.28 没食子酸当量)和抗自由基活性(超过 80%)。在这项研究中,23 名男性肾病患者和 10 名年龄和身体成分参数匹配的健康男性(对照组)被纳入并每天服用 3 粒 OFS,持续 5 周。研究结束时,肾病患者组的以下实验室参数显示出统计学上的显著降低:总胆固醇(TC)( = 0.044)、致动脉粥样硬化指数 TC/高密度脂蛋白胆固醇( = 0.010)、炎症参数(C 反应蛋白, = 0.048,红细胞沉降率, = 0.019)、收缩压( = 0.044)和舒张压动脉血压( = 0.003)。关于身体成分,总身体水分增加( = 0.035),细胞外水分分布( = 0.030)和细胞内水分( = 0.049)。在对照组中,脂肪量减少( = 0.017)和细胞外水分( = 0.047)。因此,这种 OFS 可能是对抗尿毒症相关合并症的有效辅助治疗方法。